Vertex has announced only 1 M&A deal since 2009, with the acquisition of ViroChem.

Vertex is involved in M&A activity for growth similar to its peers in the list of top pharmaceutical companies. Vertex through its strategic acquisition of ViroChem Pharma added compounds to its Hepatitis C drug development portfolio with a cash and equity transaction valued at $100 million in 2009.

Source: Current Agreements, 2014

Our report provides more detailed insight into the details of each deal. See: Partnering Deals and Alliances with Vertex

Vertex M&A at Current Agreements                        

Full details on each deal can be found at CurrentAgreements (subscription required)

Or purchase report: Partnering Deals and Alliances with Vertex 

More

Summary profile data for Vertex Pharmaceuticals

Partnering interests for Vertex Pharmaceuticals

Partnering activity for Vertex Pharmaceuticals 

Available reports from Current Partnering

Report: Partnering Agreements with Vertex Pharmaceuticals 2009-2014 

Report: Partnering Deals and Alliances with Big Biotech

Available resources for deal coverage for Vertex           

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Read: more on Vertex company profile, recent partnering, M&A and financing news and articles

Related

Report: Practical Guide to Finding Partners

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter